(Q45737949)

15 December 2017

title

Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model (English)

1 reference

15 December 2017

1 reference

vaccinia virus

1 reference

4

1 reference

15 December 2017

Weidinger G

1

1 reference

15 December 2017

Ohlmann M

series ordinal

2

1 reference

15 December 2017

Schlereth B

series ordinal

3

1 reference

15 December 2017

Niewiesk S

series ordinal

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

15 December 2017

number of pages

5

1 reference

inferred from page(s)

published in

Vaccine

1 reference

15 December 2017

volume

19

1 reference

15 December 2017

issue

20-22

1 reference

15 December 2017

page(s)

2764-2768

1 reference

Measles vaccines, new developments and immunization strategies

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Measles virus replication in lungs of hispid cotton rats after intranasal inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Replication of clinical measles virus strains in hispid cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Use of cotton rats for preclinical evaluation of measles vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900531-4

7 January 2021

10.1016/S0264-410X(00)00531-4

Identifiers

DOI

1 reference

15 December 2017

1 reference